Maria Cristina Pirosa

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti et al. · Blood · 2021 · 93 citations · Full text

Immunology, Pathology, Phenotypic Attributes +21

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

Luca Ceriani, Giuseppe Gritti, Luciano Cascione et al. · Blood Advances · 2020 · 72 citations · Full text

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy

Alessandra Romano, Nunziatina Laura Parrinello, Piera La Cava et al. · Expert Review of Molecular Diagnostics · 2018 · 69 citations

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)

Alden A. Moccia, Sämi Schär, Stefanie Hayoz et al. · British Journal of Haematology · 2020 · 33 citations · Full text

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab

Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina et al. · Blood Advances · 2021 · 26 citations · Full text

Cancer Pathology, Immunology, Pathology +19